Novo Nordisk Faces Triple Setback: What Does This Mean for Its Futur...

Headlines,Novo Nordisk has encountered three significant challenges recently, affecting its research and regulatory submissions.,The company halted a...

Anteris Technologies Pursues Nasdaq Listing and US IPO Through Re-Do...

Headlines,Anteris Technologies is planning to relocate its headquarters to the US and relist on the Nasdaq, with a secondary listing on the ASX and an...

Cardinal Health’s Q4 Earnings Preview: What to Expect and How to Opt...

Headlines,Cardinal Health is expected to release its Q4 earnings on August 14, with anticipated growth in earnings per share and revenue.,The company...

Eli Lilly vs. Johnson & Johnson: Two Pharma and Healthcare Stocks wi...

Eli Lilly (NYSE:LLY),and,Johnson & Johnson (NYSE:JNJ),are two of the most prominent players in the pharmaceutical and healthcare industries. Both comp...

Why Eli Lilly's Stock Dropped 20% Last Month

Headlines,Eli Lilly's stock fell 20% in July after Roche announced positive clinical trial results for a weight loss drug.,The competitive landscape i...

CVS Health Struggles with Medicare Business, Cuts Earnings Forecast...

CVS Health (NYSE:CVS) reported continued difficulties in its Medicare business for the second quarter, leading to another reduction in its full-year e...

Bayer's Second-Quarter Loss Misses Expectations Amid Agricultural Ma...

Bayer AG (BAYRY), the German pharmaceutical and agricultural giant, reported a significant net loss for the second quarter, falling short of analysts'...

Can Recursion Pharmaceuticals Lead to Wealth Creation?

Headlines,Current Status and Pipeline:,Recursion Pharmaceuticals is a young biotech firm with a market cap of $2.2 billion and no marketed products. I...

Avidity Biosciences Grants Stock Options and RSUs to New Chief Legal...

Headlines,Avidity Biosciences announced stock option and RSU grants to John B. Moriarty, Jr. as part of his hiring package.,The awards were granted un...

Top 9 Health Care Stocks Making Waves in August 2024

Headlines,Top Contenders:,Discover the nine standout health care stocks from the,S&P 500,, showcasing their impressive performance over the past year....

TransMedics Sees Stock Price Surge After Impressive Earnings Report

Headlnes,TransMedics reports a 118% revenue increase for Q2 2024, surpassing expectations.,The company raised its full-year 2024 revenue outlook, indi...

Is Merck a Strong Bet After Q2 Performance?

Headlines,Merck’s Q2 results exceeded revenue and earnings estimates.,Keytruda sales drove growth, but Gardasil faced shipment issues.,Stock is tradin...

Pfizer’s Bold $43 Billion Move: Is It Paying Off?

Headlines,Pfizer's acquisition of Seagen aims to boost its oncology portfolio significantly.,Seagen’s products show promise in capturing market share...

Vaccinex stock tanks 40% despite positive Alzheimer’s study update

Vaccinex Inc (NASDAQ: VCNX) tanked an alarming 40% on Wednesday despite it reporting positive early-stage results for its Alzheimer’s treatment. The b...

Why is Inari Medical Making Headlines Today

Inari Medical (,NARI,), a company specializing in minimally invasive solutions for venous and vascular diseases, released its second-quarter financial...

Tenet Healthcare (NYSE:THC) Jumps 18 Spots on Barchart’s Top 100

Tenet Healthcare,(NYSE:THC),leaped 18 places in Barchart’s Top 100 list, now ranked 67th with a weighted alpha of 119.97, surpassing its impressive 10...

ProAssurance (PRA) Soars 12.6%: What's Next?

ProAssurance (PRA) shares surged 12.6% in the last trading session, ending at $13.16. This increase was supported by significant trading volume, surpa...

Teva Pharmaceutical Industries (NYSE:TEVA) Q2 2024 Earnings Overview

The Motley Fool Stock Advisor analyst team has recently highlighted their top 10 stock selections, notably excluding Teva Pharmaceutical Industries,(N...

Procter & Gamble falls short of sales estimates: Is it still a stron...

Procter & Gamble Co (NYSE: PG), the household staple known for its broad range of consumer goods, reported weaker-than-expected sales for the four...

SCOR Q2 Loss Amid Rising Revenues; L&H CEO to Depart

Headlines:,SCOR Reports Q2 Loss Amid Mixed Revenue Growth,P&C Insurance Revenue Sees Notable Increase; L&H Revenue Marginally Declines,L&H CEO Frieder...